Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 78

1.

Clinical implications for pro-GRP in small cell lung cancer. A single center experience.

Cavalieri S, Morelli D, Martinetti A, Galli G, Nichetti F, de Braud F, Platania M.

Int J Biol Markers. 2018 Jan;33(1):55-61. doi: 10.5301/ijbm.5000305.

PMID:
28967066
2.

Progastrin: a potential predictive marker of liver metastasis in colorectal cancer.

Westwood DA, Patel O, Christophi C, Shulkes A, Baldwin GS.

Int J Colorectal Dis. 2017 Jul;32(7):1061-1064. doi: 10.1007/s00384-017-2822-8. Epub 2017 Apr 21.

PMID:
28432443
3.

Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis.

Wang H, Qian J.

J Cancer Res Ther. 2016 Dec;12(Supplement):C260-C263. doi: 10.4103/jcrt.JCRT_1118_16.

4.

Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor.

De K, Banerjee I, Sinha S, Ganguly S.

Peptides. 2017 Mar;89:17-34. doi: 10.1016/j.peptides.2017.01.002. Epub 2017 Jan 11.

PMID:
28088445
5.

Overexpression of pro-gastrin releasing peptide promotes the cell proliferation and progression in small cell lung cancer.

Gong Z, Lu R, Xie S, Jiang M, Liu K, Xiao R, Shen J, Wang Y, Guo L.

Biochem Biophys Res Commun. 2016 Oct 14;479(2):312-318. doi: 10.1016/j.bbrc.2016.09.066. Epub 2016 Sep 15.

PMID:
27639644
6.

Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells.

Hernández C, Barrachina MD, Cosín-Roger J, Ortiz-Masiá D, Álvarez Á, Terrádez L, Nicolau MJ, Alós R, Esplugues JV, Calatayud S.

PLoS One. 2014 Jun 5;9(6):e98458. doi: 10.1371/journal.pone.0098458. eCollection 2014.

7.

Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells.

Kim KW, Paul P, Qiao J, Lee S, Chung DH.

Autophagy. 2013 Oct;9(10):1579-90. doi: 10.4161/auto.25987. Epub 2013 Aug 29.

8.

Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.

Paul P, Qiao J, Kim KW, Romain C, Lee S, Volny N, Mobley B, Correa H, Chung DH.

PLoS One. 2013 Sep 9;8(9):e72570. doi: 10.1371/journal.pone.0072570. eCollection 2013.

9.

Gastrin-releasing peptide-expressing nerves comprise subsets of human cutaneous Aδ and C fibers that may sense pruritus.

Timmes TR, Rothbaum R, Kirti, Silva CY, Bhawan J, Cummins DL, Wolpowitz D.

J Invest Dermatol. 2013 Nov;133(11):2645-2647. doi: 10.1038/jid.2013.194. Epub 2013 Apr 23. No abstract available.

10.

Autophagy mediates paracrine regulation of vascular endothelial cells.

Kim KW, Paul P, Qiao J, Chung DH.

Lab Invest. 2013 Jun;93(6):639-45. doi: 10.1038/labinvest.2013.57. Epub 2013 Apr 22.

11.

Human gastrin-releasing peptide triggers growth of HepG2 cells through blocking endoplasmic reticulum stress-mediated apoptosis.

Li X, Zhang L, Ke X, Wang Y.

Biochemistry (Mosc). 2013 Jan;78(1):102-10. doi: 10.1134/S0006297913010136.

PMID:
23379566
12.

Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis.

Kagami S, Sugaya M, Suga H, Morimura S, Kai H, Ohmatsu H, Fujita H, Tsunemi Y, Sato S.

J Invest Dermatol. 2013 Jun;133(6):1673-5. doi: 10.1038/jid.2013.38. Epub 2013 Jan 25. No abstract available.

13.

Characteristics and clinical validity of two immunoassays for ProGRP.

Nordlund MS, Stieber P, Brustugun OT, Warren DJ, Paus E.

Tumour Biol. 2012 Aug;33(4):1105-13. doi: 10.1007/s13277-012-0351-1. Epub 2012 Mar 8.

PMID:
22399443
14.

Progastrin-releasing peptide is a candidate marker for quality control in clinical sample processing and storage.

Kim SY, Kim JS, Hwang SH, Park HK, Lee JH, Lee DH, Hah SS, Park DY.

Am J Clin Pathol. 2012 Feb;137(2):277-82. doi: 10.1309/AJCPDY5FPQOWA2NA.

PMID:
22261454
15.

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.

Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M.

Lung Cancer. 2011 Dec;74(3):401-4. doi: 10.1016/j.lungcan.2011.03.019. Epub 2011 Apr 29.

PMID:
21529988
16.

An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival.

Korse CM, Taal BG, Bonfrer JM, Vincent A, van Velthuysen ML, Baas P.

Ann Oncol. 2011 Dec;22(12):2625-30. doi: 10.1093/annonc/mdr007. Epub 2011 Mar 17.

PMID:
21415235
17.

Gastrin-releasing peptide: predictor of castration-resistant prostate cancer?

Heinrich E, Probst K, Michel MS, Trojan L.

Prostate. 2011 May;71(6):642-8. doi: 10.1002/pros.21280. Epub 2010 Oct 13.

PMID:
20945407
18.

Studies on multiple forms of proGRP in serum from small cell lung cancer patients.

Nordlund MS, Warren DJ, Laerdahl JK, Paus E.

Tumour Biol. 2009;30(5-6):265-75. doi: 10.1159/000258135. Epub 2009 Nov 12.

PMID:
19907206
19.

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Molina R, Augé JM, Bosch X, Escudero JM, Viñolas N, Marrades R, Ramírez J, Carcereny E, Filella X.

Tumour Biol. 2009;30(3):121-9. doi: 10.1159/000224628. Epub 2009 Jun 9.

PMID:
19506400
20.

Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons.

van den Pol AN, Yao Y, Fu LY, Foo K, Huang H, Coppari R, Lowell BB, Broberger C.

J Neurosci. 2009 Apr 8;29(14):4622-39. doi: 10.1523/JNEUROSCI.3249-08.2009.

Supplemental Content

Support Center